表纸
市场调查报告书
商品编码
1036653

自动·封闭型细胞调整系统的全球市场:工作流程,各类型,各规模的市场规模,占有率及趋势分析,各市场区隔预测(2021年~2028年)

Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation, Expansion), By Type (Non-stem Cell, Stem Cell), By Scale, And Segment Forecasts, 2021 - 2028

出版日期: | 出版商: Grand View Research, Inc. | 英文 136 Pages | 商品交期: 2-10个工作天内

价格
  • 全貌
  • 简介
  • 目录
简介

全球自动·封闭型细胞调整系统的市场规模在2020年~2028年预测期间内预计将以21.7%的年复合成长率扩大,2028年之前达到29亿4,000万美元。

市场参与者正在大力投资引入自动化过程系统,作为加速细胞治疗产品开发过程的战略,这推动了市场增长。

本报告提供全球自动·封闭型细胞调整系统市场相关调查分析,提供市场及产业展望,各市场区隔·各地区市场的展望,再加上竞争情形相关的系统性资讯。

目录

第1章 调查手法和范围

第2章 摘要整理

第3章 市场变数,趋势,范围

  • 市场区隔

第4章 产业预测

  • 母市场系统
  • 补助性的市场系统
  • 市场动态
    • 市场成长要素分析
    • 市场阻碍因素分析
    • 市场机会分析
    • 市场课题分析
  • SWOT分析;要因别(政治及法律,经济及技术性)
  • 波特的五力分析
  • 主要的交易与策略性联盟分析
    • 合并·收购
    • 技术合作和合作关系
    • 产品的认证与发售
  • Covid-19的影响分析
    • 课题分析
    • 市场机会分析
    • 主要趋势与活动

第5章 竞争分析

  • 企业的制图
  • 潜在的终端用户清单
  • 新兴企业清单
  • 市场差异化要素
  • 竞争的仪表板分析
  • 地区网路地图

第6章 各工作流程市场分析

  • 自动·封闭型细胞调整系统市场:各工作流程市场趋势分析
  • 分离
  • 扩张
  • 血球分离
  • 填充·最后润饰
  • 冻结保存
  • 其他

第7章 各类型市场分析

  • 自动·封闭型细胞调整系统市场:各类型市场趋势分析
  • 干细胞治疗
  • 非干细胞治疗

第8章 各规模市场分析

  • 自动·封闭型细胞调整系统市场:各规模市场趋势分析
  • pre商业/R&D规模制造
  • 商业规模的制造

第9章 各地区市场分析

  • 自动·封闭型细胞调整系统市场:各地区市场趋势分析
  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东·非洲

第10章 企业简介

  • 策略架构
  • 市场进入的分类
  • 企业简介
目录
Product Code: GVR-4-68038-382-9

Automated And Closed Cell Therapy Processing Systems Market Growth & Trends:

The global automated and closed cell therapy processing systems market is expected to reach USD 2.94 billion by 2028, registering a CAGR of 21.7% over the forecast period, according to a new report by Grand View Research, Inc. Market players are making significant investments to introduce an automated process system as a viable strategy to accelerate their cell therapy product development process, thereby driving market growth.

The expansion of GMP manufacturing facilities further supports the implementation of automated processes for commercial operations. In addition, the wide application scope of single-use disposable tubing sets and bags also facilitates automated processing of therapy R&D. Moreover, key entities are undertaking strategies for effective implementation of automation technology in manufacturing labs resulting in lucrative revenue growth.

The rapid growth in the cases of COVID-19 is anticipated to play a vital role in the market growth. The pandemic has led to an increased focus on automation technologies. Moreover, the companies emphasized raising funds with an aim to develop advanced therapies and regenerative medicines to fight against COVID-19. Industry players are also concentrating on the development of new therapies, such as stem cell therapy, natural killer cell therapy, exosomes, and others.

Automated And Closed Cell Therapy Processing Systems Market Report Highlights:

  • The cell expansion workflow segment accounted for the maximum revenue share of the global market in 2020. An increasing focus on achieving high output yield has resulted in the high revenue share of the segment
  • The cell separation workflow segment is estimated to register the fastest CAGR during the forecast period due to an increasing number of stem cell therapy R&D programs
  • Automated apheresis and cryopreservation workflow are also expected to register considerable growth rates over the forecast period due to the growing emphasis on preservation and sorting for cell therapies
  • The non-stem cellular therapies segment dominated the market in 2020 and will expand further at a steady CAGR over the forecast period. The success of CAR T therapies is one of the major driving forces of this segment
  • The pre-commercial/R&D scale segment captured the maximum revenue share in 2020 due to the increased number of research and innovation activities for new drug & therapy developments
  • North America emerged as the highest revenue-generating region in 2020 owing to the presence of a large number of approved therapies in the region influencing the market players to invest in more R&D programs
  • Companies are undertaking strategic initiatives, such as partnerships and collaborations, to gain higher market shares. For instance, in January 2021, Fresenius Kabiformed a joint venture with Bio-Techne to launch ScaleReady, to develop a scalable and versatile therapy manufacturing platform

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
    • 1.4.5 Details Of Primary Research
  • 1.5 Information or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
      • 1.7.1.1. Approach 1: Commodity Flow Approach
      • 1.7.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.8 Market: CAGR Calculation
  • 1.9 List of Secondary Sources
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Competition Milieu
  • 2.2 Segment Outlook
  • 2.3 Market Summary, 2020 (USD Million)

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation

Chapter 4 Industry Outlook

  • 4.1 Parent Market Lineage
  • 4.2 Ancillary Market Lineage
  • 4.3 Market Dynamics
    • 4.3.1 Market driver analysis
      • 4.3.1.1 Rising Emphasis On Regenerative Medicines And Cell Therapies
      • 4.3.1.2 Operational Superiority Of Automated Systems Over Manual Processing
      • 4.3.1.3 Extensively Increasing Technological Advancements
    • 4.3.2 Market Restraint Analysis
      • 4.3.2.1 Biological Variations Associated With Different Therapies
    • 4.3.3 Market opportunity analysis
      • 4.3.3.1 Growing Fund-Raising Activities By Companies For New Technology Development
      • 4.3.3.2 Research Activitis And Product Innovations
    • 4.3.4 Market Challenge Analysis
      • 4.3.4.1 Complicated Process Of Automation
  • 4.4 SWOT Analysis; by Factor (Political & Legal, Economic and Technological)
  • 4.5 Porter's Five Forces Analysis
  • 4.6 Major Deals and Strategic Alliances Analysis
    • 4.6.1 Mergers And Acquisitions
    • 4.6.2 Technological Collaborations And Partnerships
    • 4.6.3 Product Approvals And Launches
  • 4.7 Covid-19 Impact Analysis
    • 4.7.1 Challenge Analysis
    • 4.7.2 Opportunity Analysis
    • 4.7.3 Key Developments And Activities

Chapter 5 Competitive Analysis

  • 5.1 Company Mapping
  • 5.2 List of Potential End Users
  • 5.3 List of Emerging Players
  • 5.4 Market Differentiators
  • 5.5 Competitive Dashboard Analysis
  • 5.6 Regional Network Map

Chapter 6 Workflow Business Analysis

  • 6.1 Automated and Closed Cell Therapy Processing Systems Market: Workflow Movement Analysis
  • 6.2 Separation
    • 6.2.1 Separation Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.3 Expansion
    • 6.3.1 Expansion market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.4 Apheresis
    • 6.4.1 Apheresis market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.5 Fill-Finish
    • 6.5.1 Fill-Finish Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.6 Cryopreservation
    • 6.6.1 Cryopreservation market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.7 Others
    • 6.7.1 Others Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 7 Type Business Analysis

  • 7.1 Automated and Closed Cell Therapy Processing Systems Market: Type Movement Analysis
  • 7.2 Stem Cell Therapy
    • 7.2.1 Stem Cell Therapy Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 7.3 Non-Stem Cell Therapy
    • 7.3.1 Non-Stem Cell Therapy Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 8 Scale Business Analysis

  • 8.1 Automated and Closed Cell Therapy Processing Systems Market: Scale Movement Analysis
  • 8.2 Pre-Commercial/R&D Scale Manufacturing
    • 8.2.1 Pre-Commercial/R&D Scale Manufacturing Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 8.3 Commercial Scale Manufacturing
    • 8.3.1 Commercial Scale Manufacturing Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 9 Regional Business Analysis

  • 9.1 Automated and Closed Cell Therapy Processing Systems Market: Regional Movement Analysis
  • 9.2 North America
    • 9.2.1 North America Automated And Closed Cell Therapy Processing Sysytems Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 U.S. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.2.2.2 U.S. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.2.2.3 U.S. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.2.3.2 Canada Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.2.3.3 Canada Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.2 Germany
      • 9.3.2.1 Germany Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.2.2 Germany Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.2.3 Germany Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.3 U.K.
      • 9.3.3.1 U.K. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.3.2 U.K. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.3.3 U.K. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.4 France
      • 9.3.4.1 France Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.4.2 France Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.4.3 France Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.5 Italy
      • 9.3.5.1 Italy Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.5.2 Italy Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.5.3 Italy Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.6 Spain
      • 9.3.6.1 Spain Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.6.2 Spain Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.6.3 Spain Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific Automated And Closed Cell Therapy Processing Systems Market estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.4.2 Japan
      • 9.4.2.1 Japan Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.2.2 Japan Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.2.3 Japan Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.4.3 China
      • 9.4.3.1 China Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.3.2 China Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.3.3 China Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.4.4 India
      • 9.4.4.1 India Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.4.2 India Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.4.3 India Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.4.5 South Korea
      • 9.4.5.1 South Korea Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.5.2 South Korea Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.5.3 South Korea Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.4.6 Australia
      • 9.4.6.1 Australia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.6.2 Australia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.6.3 Australia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America automated And Closed Cell Therapy Processing Systems Market estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.5.2.2 Brazil Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.5.2.3 Brazil Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.5.3 Mexico
      • 9.5.3.1 Mexico Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.5.3.2 Mexico Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.5.3.3 Mexico Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
  • 9.6 Middle East & Africa
    • 9.6.1 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 South Africa Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.6.2.2 South Africa Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.6.2.3 South Africa Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.6.3 Saudi Arabia
      • 9.6.3.1 Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.6.3.2 Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.6.3.3 Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.6.4 UAE
      • 9.6.4.1 UAE Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.6.4.2 UAE Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.6.4.3 UAE Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)

Chapter 10 Company Profiles

  • 10.1 Strategy Framework
  • 10.2 Market Participation Categorization
  • 10.3 Company Profiles
    • 10.3.1 MILTENYI BIOTEC
      • 10.3.1.1 Company Overview
      • 10.3.1.2 Product Benchmarking
      • 10.3.1.3 Strategic Initiatives
    • 10.3.2 LONZA
      • 10.3.2.1 Company Overview
      • 10.3.2.2 Financial Performance
      • 10.3.2.3 Product Benchmarking
      • 10.3.2.4 Strategic Initiatives
    • 10.3.3 FRESENIUS KABI
      • 10.3.3.1 Company Overview
      • 10.3.3.2 Financial Performance
      • 10.3.3.3 Product Benchmarking
      • 10.3.3.4 Startegic Initiatives
    • 10.3.4 CYTIVA (DANAHER CORPORATION)
      • 10.3.4.1 Company Overview
      • 10.3.4.2 Financial Performance
      • 10.3.4.3 Product Benchmarking
      • 10.3.4.4 Startegic Initiatives
    • 10.3.5 BIOSPHERIX, LTD.
      • 10.3.5.1 Company Overview
      • 10.3.5.2 Product Benchmarking
      • 10.3.5.3 Startegic Initiatives
    • 10.3.6 TERUMO CORPORATION
      • 10.3.6.1 Company Overview
      • 10.3.6.2 Financial Performance
      • 10.3.6.3 Product Benchmarking
      • 10.3.6.4 Startegic Initiatives
    • 10.3.7 SARTORIUS AG
      • 10.3.7.1 Company Overview
      • 10.3.7.2 Financial Performance
      • 10.3.7.3 Product Benchmarking
      • 10.3.7.4 Startegic Initiatives
    • 10.3.8 THERMOGENESIS HOLDINGS, INC.
      • 10.3.8.1 Company Overview
      • 10.3.8.2 Financial Performance
      • 10.3.8.3 Product Benchmarking
      • 10.3.8.4 Startegic Initiatives
    • 10.3.9 CELLARES INC.
      • 10.3.9.1 Company Overview
      • 10.3.9.2 Product Benchmarking
      • 10.3.9.3 Startegic Initiatives
    • 10.3.10 THERMO FISHER SCIENTIFIC, INC.
      • 10.3.10.1 Company Overview
      • 10.3.10.2 Financial Performance
      • 10.3.10.3 Product Benchmarking
      • 10.3.10.4 Startegic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of automated and closed cell therapy processing systems manufacturers
  • Table 3 List of potential end-users
  • Table 4 List of emerging players
  • Table 5 List of market differentiators
  • Table 6 Competitive dashboard analysis
  • Table 7 Regional network map
  • Table 8 North America automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 9 North America automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 10 North America automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 11 U.S. automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 12 U.S. automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 13 U.S. automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 14 Canada automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 15 Canada automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 16 Canada automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 17 Europe automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 18 Europe automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 19 Europe automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 20 Germany automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 21 Germany automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 22 Germany automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 23 U.K. automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 24 U.K. automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 25 U.K. automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 26 Italy automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 27 Italy automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 28 Italy automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 29 Spain automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 30 Spain automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 31 Spain automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 32 France automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 33 France automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 34 France America automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 35 Asia Pacific automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 36 Asia Pacific automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 37 Asia Pacific automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 38 China automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 39 China automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 40 China automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 41 Japan automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 42 Japan automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 43 Japan automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 44 India automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 45 India automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 46 India automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 47 South Korea automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 48 South Korea automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 49 South Korea automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 50 Australia automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 51 Australia automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 52 Australia automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 53 Latin America automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 54 Latin America automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 55 Latin America automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 56 Brazil automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 57 Brazil automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 58 Brazil automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 59 Mexico automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 60 Mexico automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 61 Mexico automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 62 MEA automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 63 MEA automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 64 MEA automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 65 South Africa automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 66 South Africa automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 67 South Africa automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 68 Saudi Arabia automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 69 Saudi Arabia automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 70 Saudi Arabia automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 71 UAE automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 72 UAE automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 73 UAE automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Classification of companies
  • Fig. 9 Automated and closed cell therapy processing systems market snapshot, 2020 (USD Million)
  • Fig. 10 Automated and Closed Cell Therapy Processing System Market segmentation
  • Fig. 11 Market driver impact
  • Fig. 12 Market restraint impact
  • Fig. 13 Automated and closed cell therapy processing systems market SWOT analysis
  • Fig. 14 Automated and closed cell therapy processing systems market Porter's five forces analysis
  • Fig. 15 Automated and closed cell therapy processing systems market : Workflow outlook and key takeaways
  • Fig. 16 Automated and closed cell therapy processing systems market : Workflow movement analysis
  • Fig. 17 Separation market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 18 Expansion market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 19 Apheres is market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 20 Fill-Finish market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 21 Cryopreservation market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 22 Others market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 23 Automated and closed cell therapy processing systems market : Type outlook and key takeaways
  • Fig. 24 Automated and closed cell therapy processing systems market : Type movement analysis
  • Fig. 25 Stem cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 26 Non-stem cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 27 Automated and closed cell therapy processing systems market : Scaleoutlook and key takeaways
  • Fig. 28 Automated and closed cell therapy processing systems market : Scale movement analysis
  • Fig. 29 Pre-commercial/ R&D scale manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 30 Commercial scale manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 31 Automated and closed cell therapy processing systems market : Regional outlook and key takeaways
  • Fig. 32 Automated and closed cell therapy processing systems market : Regional movement analysis
  • Fig. 33 North America automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 34 U.S. automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 35 Canada cell and gene therapy manufacturing) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 36 Europe automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 37 Germany automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 38 U.K. automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 39 France automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 40 Italy automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 41 Spain automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 42 Asia Pacific automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 43 Japan automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 44 China automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 45 India automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 46 South Korea automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 47 Australia automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 48 Latin America automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 49 Brazil automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 50 Mexico automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 51 Middle East & Africa automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 52 South Africa automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 53 Saudi Arabia automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 54 UAE automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 55 Strategy framework
  • Fig. 56 Market participation categorization